Grupo farmacéutico · Estados Unidos
Abbott
Un grupo de 29 empresas con 577 medicamentos en 9 países.
Estructura del grupo
29 empresas en 12 países
Cargando…
Grupo farmacéutico · Estados Unidos
Un grupo de 29 empresas con 577 medicamentos en 9 países.
29 empresas en 12 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 577
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| A-POXIDE10mg | 25mg | 5mg · Capsule | Chlordiazepoxide | Estados Unidos | No comercializado | 1977 |
| ALIVETORE | Etoricoxib | Brasil | Autorizado | 2024 |
| AMINOSYN 3.5% IN PLASTIC CONTAINER3.5% (3.5gm/100ml) · Injectable | Amino acids | Estados Unidos | No comercializado | |
| AMINOSYN 3.5% M IN PLASTIC CONTAINER3.5%; 21mg/100ml; 40mg/100ml; 128mg/100ml; 234mg/100ml · Injectable | Amino acids, Magnesium acetate, Phosphoric acid, Potassium acetate, Sodium chloride | Estados Unidos | No comercializado | |
| AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER3.5%; 25gm/100ml · Injectable | Amino acids, Dextrose | Estados Unidos | No comercializado | |
| AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER3.5%; 5gm/100ml · Injectable | Amino acids, Dextrose | Estados Unidos | No comercializado | |
| AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER4.25%; 25gm/100ml · Injectable | Amino acids, Dextrose | Estados Unidos | No comercializado | |
| AMINOSYN-HBC 7% IN PLASTIC CONTAINER7% (7gm/100ml) · Injectable | Amino acids | Estados Unidos | No comercializado | |
| AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER3.5%; 25gm/100ml · Injectable | Amino acids, Dextrose | Estados Unidos | No comercializado | 1988 |
| AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER3.5%; 5gm/100ml · Injectable | Amino acids, Dextrose | Estados Unidos | No comercializado | 1988 |
| AMINOSYN II 3.5% IN PLASTIC CONTAINER3.5% (3.5gm/100ml) · Injectable | Amino acids | Estados Unidos | No comercializado | |
| AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER3.5%; 5gm/100ml; 30mg/100ml; 97mg/100ml; 120mg/100ml; 49.3mg/100ml · Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride, Sodium phosphate, Dibasic, Heptahydrate | Estados Unidos | No comercializado | 1986 |
| AMINOSYN II 3.5% M IN PLASTIC CONTAINER3.5%; 32mg/100ml; 128mg/100ml; 222mg/100ml; 49mg/100ml · Injectable | Amino acids, Magnesium acetate, Potassium acetate, Sodium chloride, Sodium phosphate, Dibasic, Heptahydrate | Estados Unidos | No comercializado | |
| AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER3.5%; 25gm/100ml; 51mg/100ml; 22.4mg/100ml; 261mg/100ml; 205mg/100ml · Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Potassium phosphate, Dibasic, Sodium chloride | Estados Unidos | No comercializado | 1986 |
| AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER4.25%; 10gm/100ml · Injectable | Amino acids, Dextrose | Estados Unidos | No comercializado | 1988 |
| AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER4.25%; 20gm/100ml · Injectable | Amino acids, Dextrose | Estados Unidos | No comercializado | 1988 |
| AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER4.25%; 25gm/100ml · Injectable | Amino acids, Dextrose | Estados Unidos | No comercializado | 1988 |
| AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER4.25%; 10gm/100ml; 30mg/100ml; 97mg/100ml; 120mg/100ml; 49.3mg/100ml | 4.25%; 5gm/100ml; 30mg/100ml; 97mg/100ml; 120mg/100ml; 49.3mg/100ml · Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride, Sodium phosphate, Dibasic, Heptahydrate | Estados Unidos | No comercializado | 1986 |
| AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER4.25%; 25gm/100ml; 51mg/100ml; 22.4mg/100ml; 261mg/100ml; 205mg/100ml · Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Potassium phosphate, Dibasic, Sodium chloride | Estados Unidos | No comercializado | 1986 |
| AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER5%; 25gm/100ml · Injectable | Amino acids, Dextrose | Estados Unidos | No comercializado | 1986 |
| Batrevac, suspensie voor injectie in voorgevulde spuit 0,5 mlSuspensie voor injectie | A-darwin-1454-2025 -achtige stam, A-missouri-11-2025 pdm09-achtige stam, B-tokyo-eis13-175-2025-achtige stam | Países Bajos | Autorizado | 1999 |
| BETASERC | Betahistine | Brasil | Autorizado | 2011 |
| BETASERC 24 TABLET 24 mg24 mg · Tablet | Betahistine | Singapur | Autorizado | 2003 |
| BETASERC TABLETS 16 mg16 mg · Tablet | Betahistine | Singapur | Autorizado | 2000 |
| BISINTEX | Trastuzumab | Brasil | Autorizado | 2025 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Brasil | 267 | 45 | 222 | EmpresasTodos los medicamentos |
| Canadá | 112 | 0 | 112 | EmpresasTodos los medicamentos |
| Arabia Saudí | 71 | 71 | 0 | EmpresasTodos los medicamentos |
| Estados Unidos | 60 | 60 | 0 | EmpresasTodos los medicamentos |
| Singapur | 45 | 45 | 0 | EmpresasTodos los medicamentos |
| Países Bajos | 16 | 16 | 0 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 4 | 0 | 4 | EmpresasTodos los medicamentos |
| España | 1 | 0 | 1 | EmpresasTodos los medicamentos |
| Taiwán | 1 | 0 | 1 | EmpresasTodos los medicamentos |
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licencia: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Companies House, Find and update company information; exact company number and page URL, accessed 8 October 2026. Structured factual extraction by Prognia. Crown-created website material under OGL 3.0: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Licencia: Companies House statutory public-register use; OGL 3.0 for Crown-created website material
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licencia: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Oficiul Național al Registrului Comerțului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licencia: Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licencia: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates
Licencia: Taiwan Government Open Data Licence
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Abbott en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.
Ordenados por su número de medicamentos.